Meijer C - Search Results

1

Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk.

Grasso C, Popovic M, Isaevska E, Lazzarato F, Fiano V, Zugna D, Pluta J, Weathers B, D'Andrea K, Almstrup K, Anson-Cartwright L, Bishop DT, Chanock SJ, Chen C, Cortessis VK, Dalgaard MD, Daneshmand S, Ferlin A, Foresta C, Frone MN, Gamulin M, Gietema JA, Greene MH, Grotmol T, Hamilton RJ, Haugen TB, Hauser R, Karlsson R, Kiemeney LA, Lessel D, Lista P, Lothe RA, Loveday C, Meijer C, Nead KT, Nsengimana J, Skotheim RI, Turnbull C, Vaughn DJ, Wiklund F, Zheng T, Zitella A, Schwartz SM, McGlynn KA, Kanetsky PA, Nathanson KL, Richiardi L. Grasso C, et al. Among authors: meijer c. Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1769-1779. doi: 10.1158/1055-9965.EPI-22-0123. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35700037 Free PMC article.

2

Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patients.

Nuver J, Lutke Holzik MF, van Zweeden M, Hoekstra HJ, Meijer C, Suurmeijer AJ, Groen HJ, Hofstra RM, Sluiter WJ, Groen H, Sleijfer DT, Gietema JA. Nuver J, et al. Among authors: meijer c. Pharmacogenet Genomics. 2005 Jun;15(6):399-405. doi: 10.1097/01213011-200506000-00005. Pharmacogenet Genomics. 2005. PMID: 15900213

3

Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.

de Haas EC, Zwart N, Meijer C, Nuver J, Boezen HM, Suurmeijer AJ, Hoekstra HJ, van der Steege G, Sleijfer DT, Gietema JA. de Haas EC, et al. Among authors: meijer c. J Clin Oncol. 2008 Apr 10;26(11):1817-23. doi: 10.1200/JCO.2007.14.1606. J Clin Oncol. 2008. PMID: 18398146

4

Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer.

de Haas EC, di Pietro A, Simpson KL, Meijer C, Suurmeijer AJ, Lancashire LJ, Cummings J, de Jong S, de Vries EG, Dive C, Gietema JA. de Haas EC, et al. Among authors: meijer c. Neoplasia. 2008 Oct;10(10):1041-8. doi: 10.1593/neo.08620. Neoplasia. 2008. PMID: 18813353 Free PMC article.

5

Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro.

Nuver J, De Haas EC, Van Zweeden M, Gietema JA, Meijer C. Nuver J, et al. Among authors: meijer c. Oncol Rep. 2010 Jan;23(1):247-53. Oncol Rep. 2010. PMID: 19956889

6

Association of PAI-1 gene polymorphism with survival and chemotherapy-related vascular toxicity in testicular cancer.

de Haas EC, Zwart N, Meijer C, Suurmeijer AJ, Meijer K, Guchelaar HJ, Hoekstra HJ, van Leeuwen FE, Sleijfer DT, Boezen HM, Gietema JA. de Haas EC, et al. Among authors: meijer k, meijer c. Cancer. 2010 Dec 15;116(24):5628-36. doi: 10.1002/cncr.25300. Epub 2010 Aug 24. Cancer. 2010. PMID: 20737565 Free article.

7

Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage.

Altena R, Fehrmann RS, Boer H, de Vries EG, Meijer C, Gietema JA. Altena R, et al. Among authors: meijer c. PLoS One. 2015 Jan 15;10(1):e0115372. doi: 10.1371/journal.pone.0115372. eCollection 2015. PLoS One. 2015. PMID: 25590623 Free PMC article.

8

Single-nucleotide polymorphism in the 5-α-reductase gene (SRD5A2) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors.

Boer H, Westerink NL, Altena R, Nuver J, Dijck-Brouwer DAJ, van Faassen M, Klont F, Kema IP, Lefrandt JD, Zwart N, Boezen HM, Smit AJ, Meijer C, Gietema JA. Boer H, et al. Among authors: meijer c. Eur J Cancer. 2016 Feb;54:104-111. doi: 10.1016/j.ejca.2015.11.009. Epub 2016 Jan 2. Eur J Cancer. 2016. PMID: 26751392

9

Variation in the HFE gene is associated with the development of bleomycin-induced pulmonary toxicity in testicular cancer patients.

van der Schoot GGF, Westerink NL, Lubberts S, Nuver J, Zwart N, Walenkamp AME, Wempe JB, Meijer C, Gietema JA. van der Schoot GGF, et al. Among authors: meijer c. Eur J Cancer. 2016 May;59:134-141. doi: 10.1016/j.ejca.2016.02.013. Epub 2016 Mar 28. Eur J Cancer. 2016. PMID: 27033261

10

Insulin-like factor 3, luteinizing hormone and testosterone in testicular cancer patients: effects of β-hCG and cancer treatment.

Steggink LC, van Beek AP, Boer H, Meijer C, Lubberts S, Oosting SF, de Jong IJ, van Ginkel RJ, Lefrandt JD, Gietema JA, Nuver J. Steggink LC, et al. Among authors: meijer c. Andrology. 2019 Jul;7(4):441-448. doi: 10.1111/andr.12581. Epub 2019 Jan 4. Andrology. 2019. PMID: 30609309 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,372 results

Search Page